- Home
- STRM vs CTXR Comparison
STRM vs CTXR Comparison
Compare STRM & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- CTXR
- Stock Information
- Founded
- STRM 1989
- CTXR 2007
- Country
- STRM United States
- CTXR United States
- Employees
- STRM N/A
- CTXR N/A
- Industry
- STRM EDP Services
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- CTXR Health Care
- Exchange
- STRM Nasdaq
- CTXR Nasdaq
- Market Cap
- STRM 15.4M
- CTXR 14.6M
- IPO Year
- STRM 1996
- CTXR N/A
- Fundamental
- Price
- STRM $3.14
- CTXR $1.55
- Analyst Decision
- STRM
- CTXR Strong Buy
- Analyst Count
- STRM 0
- CTXR 2
- Target Price
- STRM N/A
- CTXR $54.50
- AVG Volume (30 Days)
- STRM 11.7K
- CTXR 179.2K
- Earning Date
- STRM 04-28-2025
- CTXR 02-14-2025
- Dividend Yield
- STRM N/A
- CTXR N/A
- EPS Growth
- STRM N/A
- CTXR N/A
- EPS
- STRM N/A
- CTXR N/A
- Revenue
- STRM $18,587,000.00
- CTXR N/A
- Revenue This Year
- STRM N/A
- CTXR N/A
- Revenue Next Year
- STRM $4.04
- CTXR $383.98
- P/E Ratio
- STRM N/A
- CTXR N/A
- Revenue Growth
- STRM N/A
- CTXR N/A
- 52 Week Low
- STRM $1.85
- CTXR $1.47
- 52 Week High
- STRM $9.75
- CTXR $26.75
- Technical
- Relative Strength Index (RSI)
- STRM 37.14
- CTXR 27.42
- Support Level
- STRM $3.05
- CTXR $1.50
- Resistance Level
- STRM $3.27
- CTXR $1.87
- Average True Range (ATR)
- STRM 0.18
- CTXR 0.15
- MACD
- STRM -0.03
- CTXR 0.03
- Stochastic Oscillator
- STRM 12.68
- CTXR 13.16
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.